194 related articles for article (PubMed ID: 22327976)
1. Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study.
Chong W; Li Y; Liu B; Liu Z; Zhao T; Wonsey DR; Chen C; Velmahos GC; deMoya MA; King DR; Kung AL; Alam HB
J Trauma Acute Care Surg; 2012 Feb; 72(2):347-53; discussion 353-4. PubMed ID: 22327976
[TBL] [Abstract][Full Text] [Related]
2. Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock.
Li Y; Liu B; Fukudome EY; Lu J; Chong W; Jin G; Liu Z; Velmahos GC; Demoya M; King DR; Alam HB
Surgery; 2011 Sep; 150(3):442-51. PubMed ID: 21878229
[TBL] [Abstract][Full Text] [Related]
3. Surviving lethal septic shock without fluid resuscitation in a rodent model.
Li Y; Liu B; Fukudome EY; Kochanek AR; Finkelstein RA; Chong W; Jin G; Lu J; deMoya MA; Velmahos GC; Alam HB
Surgery; 2010 Aug; 148(2):246-54. PubMed ID: 20561658
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.
Chong W; Li Y; Liu B; Zhao T; Fukudome EY; Liu Z; Smith WM; Velmahos GC; deMoya MA; Alam HB
J Surg Res; 2012 Dec; 178(2):851-9. PubMed ID: 22868051
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
Li Y; Liu B; Zhao H; Sailhamer EA; Fukudome EY; Zhang X; Kheirbek T; Finkelstein RA; Velmahos GC; deMoya M; Hales CA; Alam HB
Shock; 2009 Nov; 32(5):517-23. PubMed ID: 19295477
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G
Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition.
Hutt DM; Roth DM; Vignaud H; Cullin C; Bouchecareilh M
PLoS One; 2014; 9(8):e106224. PubMed ID: 25166596
[TBL] [Abstract][Full Text] [Related]
8. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Molecular Hydrogen and Suberoylanilide Hydroxamic Acid on Paraquat-Induced Production of Reactive Oxygen Species and TNF-α in Macrophages.
Li J; Wu X; Chen Y; Zeng R; Zhao Y; Chang P; Wang D; Zhao Q; Deng Y; Li Y; Alam HB; Chong W
Inflammation; 2016 Dec; 39(6):1990-1996. PubMed ID: 27624060
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic "second hit" in leukocytes from trauma patients: Modulation of the immune response by histone deacetylase inhibition.
Sailhamer EA; Li Y; Smith EJ; Liu B; Shuja F; Soupir CP; DeMoya MA; Velmahos GC; Alam HB
Cytokine; 2010 Mar; 49(3):303-11. PubMed ID: 20056553
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
12. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents.
Zhao Y; Zhou P; Liu B; Bambakidis T; Mazitschek R; Alam HB; Li Y
J Surg Res; 2015 Apr; 194(2):544-550. PubMed ID: 25479907
[TBL] [Abstract][Full Text] [Related]
14. The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer.
Tran K; Risingsong R; Royce DB; Williams CR; Sporn MB; Pioli PA; Gediya LK; Njar VC; Liby KT
Carcinogenesis; 2013 Jan; 34(1):199-210. PubMed ID: 23042302
[TBL] [Abstract][Full Text] [Related]
15. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
16. Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.
Finkelstein RA; Li Y; Liu B; Shuja F; Fukudome E; Velmahos GC; deMoya M; Alam HB
J Surg Res; 2010 Sep; 163(1):146-54. PubMed ID: 20599223
[TBL] [Abstract][Full Text] [Related]
17. Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
Lu J; Chatain GP; Bugarini A; Wang X; Maric D; Walbridge S; Zhuang Z; Chittiboina P
J Clin Endocrinol Metab; 2017 Aug; 102(8):2825-2835. PubMed ID: 28505327
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxia inducible factor-1α ameliorates lung injury induced by trauma and hemorrhagic shock in rats.
Jiang H; Huang Y; Xu H; Hu R; Li QF
Acta Pharmacol Sin; 2012 May; 33(5):635-43. PubMed ID: 22465950
[TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
20. Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7.
Liu YN; Pan SL; Liao CH; Huang DY; Guh JH; Peng CY; Chang YL; Teng CM
Shock; 2009 Sep; 32(3):263-9. PubMed ID: 19106818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]